FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2586802561> ?p ?o ?g. }

• W2586802561 endingPage "50813" @default.
• W2586802561 startingPage "50804" @default.
• W2586802561 abstract "Prostate cancer antigen 3 (PCA3) is a prostate cancer diagnostic biomarker that has been clinically validated. The limitations of the diagnostic role of PCA3 in initial biopsy and the prognostic role are not well established. Here, we elucidate the limitations of tissue PCA3 to predict high grade tumors in initial biopsy.PCA3 has a bimodal distribution in both biopsy and radical prostatectomy (RP) tissues, where low PCA3 expression was significantly associated with high grade disease (p<0.001). PCA3 had a poor performance of predicting high grade disease in initial biopsy (GS≥8) with 55% sensitivity and high false negative rates; 42% of high Gleason (≥8) samples had low PCA3. In RP, low PCA3 is associated with adverse pathological features, clinical recurrence outcome and greater probability of metastatic progression (p<0.001).A total of 1,694 expression profiles from biopsy and 10,382 from RP patients with high risk tumors were obtained from the Decipher Genomic Resource Information Database (GRIDTM)prostate cancer database. The primary clinical endpoint was distant metastasis-free survival for RP and high Gleason grade for biopsy. Logistic regression analyses and Cox proportional hazards models were used to evaluate the association of PCA3 with clinical variables and risk of metastasis.There is high prevalence of high grade tumors with low PCA3 expression in the biopsy setting. Therefore, urologists should be warned that using PCA3 as stand-alone test may lead to high rate of under-diagnosis of high grade disease in initial biopsy setting." @default.
• W2586802561 created "2017-02-17" @default.
• W2586802561 creator A5001069772 @default.
• W2586802561 creator A5012304744 @default.
• W2586802561 creator A5013881851 @default.
• W2586802561 creator A5014582211 @default.
• W2586802561 creator A5024263446 @default.
• W2586802561 creator A5028202093 @default.
• W2586802561 creator A5029053607 @default.
• W2586802561 creator A5029125718 @default.
• W2586802561 creator A5032201078 @default.
• W2586802561 creator A5033660195 @default.
• W2586802561 creator A5036003731 @default.
• W2586802561 creator A5039646183 @default.
• W2586802561 creator A5042227397 @default.
• W2586802561 creator A5044704274 @default.
• W2586802561 creator A5054652534 @default.
• W2586802561 creator A5060302039 @default.
• W2586802561 creator A5067282152 @default.
• W2586802561 creator A5076810623 @default.
• W2586802561 creator A5081746672 @default.
• W2586802561 creator A5086689290 @default.
• W2586802561 date "2017-02-07" @default.
• W2586802561 modified "2023-10-16" @default.
• W2586802561 title "Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients" @default.
• W2586802561 cites W1508662657 @default.
• W2586802561 cites W1537007105 @default.
• W2586802561 cites W158725487 @default.
• W2586802561 cites W1607198229 @default.
• W2586802561 cites W1970408952 @default.
• W2586802561 cites W1972298018 @default.
• W2586802561 cites W1974473517 @default.
• W2586802561 cites W1974720903 @default.
• W2586802561 cites W1990786792 @default.
• W2586802561 cites W1998343146 @default.
• W2586802561 cites W2025299655 @default.
• W2586802561 cites W2031320118 @default.
• W2586802561 cites W2034536490 @default.
• W2586802561 cites W2040672147 @default.
• W2586802561 cites W2053135029 @default.
• W2586802561 cites W2056465289 @default.
• W2586802561 cites W2091288012 @default.
• W2586802561 cites W2098905361 @default.
• W2586802561 cites W2100893713 @default.
• W2586802561 cites W2106556127 @default.
• W2586802561 cites W2114909008 @default.
• W2586802561 cites W2132803044 @default.
• W2586802561 cites W2135156445 @default.
• W2586802561 cites W2151494814 @default.
• W2586802561 cites W2160947271 @default.
• W2586802561 cites W2169385858 @default.
• W2586802561 cites W2175637948 @default.
• W2586802561 cites W2250188469 @default.
• W2586802561 cites W2296343843 @default.
• W2586802561 cites W2341689870 @default.
• W2586802561 cites W2487276065 @default.
• W2586802561 cites W2537609933 @default.
• W2586802561 cites W2917837889 @default.
• W2586802561 doi "https://doi.org/10.18632/oncotarget.15133" @default.
• W2586802561 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5584206" @default.
• W2586802561 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28881605" @default.
• W2586802561 hasPublicationYear "2017" @default.
• W2586802561 type Work @default.
• W2586802561 sameAs 2586802561 @default.
• W2586802561 citedByCount "29" @default.
• W2586802561 countsByYear W25868025612017 @default.
• W2586802561 countsByYear W25868025612018 @default.
• W2586802561 countsByYear W25868025612019 @default.
• W2586802561 countsByYear W25868025612020 @default.
• W2586802561 countsByYear W25868025612021 @default.
• W2586802561 countsByYear W25868025612022 @default.
• W2586802561 countsByYear W25868025612023 @default.
• W2586802561 crossrefType "journal-article" @default.
• W2586802561 hasAuthorship W2586802561A5001069772 @default.
• W2586802561 hasAuthorship W2586802561A5012304744 @default.
• W2586802561 hasAuthorship W2586802561A5013881851 @default.
• W2586802561 hasAuthorship W2586802561A5014582211 @default.
• W2586802561 hasAuthorship W2586802561A5024263446 @default.
• W2586802561 hasAuthorship W2586802561A5028202093 @default.
• W2586802561 hasAuthorship W2586802561A5029053607 @default.
• W2586802561 hasAuthorship W2586802561A5029125718 @default.
• W2586802561 hasAuthorship W2586802561A5032201078 @default.
• W2586802561 hasAuthorship W2586802561A5033660195 @default.
• W2586802561 hasAuthorship W2586802561A5036003731 @default.
• W2586802561 hasAuthorship W2586802561A5039646183 @default.
• W2586802561 hasAuthorship W2586802561A5042227397 @default.
• W2586802561 hasAuthorship W2586802561A5044704274 @default.
• W2586802561 hasAuthorship W2586802561A5054652534 @default.
• W2586802561 hasAuthorship W2586802561A5060302039 @default.
• W2586802561 hasAuthorship W2586802561A5067282152 @default.
• W2586802561 hasAuthorship W2586802561A5076810623 @default.
• W2586802561 hasAuthorship W2586802561A5081746672 @default.
• W2586802561 hasAuthorship W2586802561A5086689290 @default.
• W2586802561 hasBestOaLocation W25868025611 @default.
• W2586802561 hasConcept C121608353 @default.
• W2586802561 hasConcept C126322002 @default.
• W2586802561 hasConcept C142724271 @default.
• W2586802561 hasConcept C143998085 @default.

• next